548 Odcinki

  1. Choosing the Right Viral Vector for a Gene Therapy

    Opublikowany: 1.04.2021
  2. A Software Platform to Give Patients the Tools to Build Treatments for Rare Genetic Diseases

    Opublikowany: 25.03.2021
  3. Side Effects: The Toll a Rare Disease Can Take on a Family in Pursuit of a Cure

    Opublikowany: 19.03.2021
  4. Realizing the Potential of CRISPR Gene Editing

    Opublikowany: 12.03.2021
  5. Understanding the Economic Toll of Rare Disease in the United States

    Opublikowany: 4.03.2021
  6. The Promise of Gene-Based Therapies for Neurodegenerative Conditions

    Opublikowany: 25.02.2021
  7. Moving Beyond Viral Vectors for Gene Therapies

    Opublikowany: 19.02.2021
  8. Acquisitions Help Jazz Build Toward Commercial Crescendo

    Opublikowany: 12.02.2021
  9. Powerful Gene Editing Approach Offers the Promise of Correcting a Range of Rare Diseases

    Opublikowany: 5.02.2021
  10. A Child's-Eye-View of Clinical Trials

    Opublikowany: 29.01.2021
  11. Using Nanoliposomes to Make Cancer Therapies Safer and More Effective

    Opublikowany: 21.01.2021
  12. Accelerating Treatments for Rare Disease through Data Sharing

    Opublikowany: 14.01.2021
  13. Treating the Root Cause of Sickle Cell Disease

    Opublikowany: 8.01.2021
  14. Targeting a Common Pathway in Genetic Forms of Obesity

    Opublikowany: 30.12.2020
  15. After Pruning Orchard, Gaspar Focuses on High Value Opportunities

    Opublikowany: 23.12.2020
  16. Writing a New Chapter of Genetic Medicine

    Opublikowany: 17.12.2020
  17. How an Ultra-Rare Disease Patient Organization Drove Research to a Treatment

    Opublikowany: 10.12.2020
  18. With a New Identity, Travere Thearpeutics Seeks to Find Its True Path

    Opublikowany: 4.12.2020
  19. Making Gene Therapies Accessible to Patient with Ultra-Rare Conditions

    Opublikowany: 26.11.2020
  20. Using RNA Therapies to Target Inherited Retinal Diseases

    Opublikowany: 20.11.2020

12 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site